ALDA Pharmaceuticals Corp.
TSX VENTURE : APH

ALDA Pharmaceuticals Corp.

March 03, 2008 13:30 ET

ALDA Satisfied With First T36® Samples Made in China

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 3, 2008) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) ("ALDA") has received the first samples of T36® Disinfectant that were prepared in China by He-Yi She Ye Limited ("He-Yi"). Quality control analyses conducted for ALDA by an independent laboratory in Vancouver revealed that the "Made in China" formulation requires only a simple reduction in the concentration of one of the active ingredients to meet all of the required specifications. Pilot-scale manufacturing can now proceed as soon as the manufacturing facility is ready. The objective is to have the facility in operation as soon as possible so that T36® products can be on the market in China prior to 2008 Summer Olympics in Beijing.

Dr. Terrance Owen, President & CEO, states, "The fact that He-Yi has been able to independently prepare these samples of T36® demonstrates that the technology is very robust and that we can now move forward with our plans in China with confidence. Our partners are very motivated to complete the manufacturing facility and start generating sales in China so that we can achieve the international exposure that will come with the Olympics. This exposure is very important to ALDA because He Yi obtained approval for the formulation as a hand sanitizer and first-aid ointment as well as a disinfectant. These medical applications will serve as an early test market for our products."

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection control therapeutics derived from its patented T36® technology. The company trades on the TSX Venture Exchange under the symbol APH.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • ALDA Pharmaceuticals Corp.
    Terrance G. Owen, Ph.D., MBA
    President, CEO and Director
    (604) 521-8300
    or
    ALDA Pharmaceuticals Corp. - Distribution & Sales Contact
    Peter Chen
    CFO and Director
    (604) 521-8300 Ext. 3
    (604) 521-8322 (FAX)
    Email: peter_chen@aldacorp.com
    or
    ALDA Pharmaceuticals Corp. - Investor Relations Contact
    Scott Young
    (604) 288-7222
    Email: syoung@freeformcom.com
    Website: www.aldacorp.com